大柴胡汤加减治疗肝癌TACE术后栓塞综合征  

Dachaihu Decoction in the treatment of embolism syndrome after interventional therapy on primary hepatocellular carcinoma

作　　者：李永伟[1] 杨宏志[1] 王拥泽[1] 滕立春[1] 

机构地区：[1]中山大学附属第三医院中医科,广东广州510630

出　　处：《中国医药导报》2012年第28期107-108,110,共3页China Medical Herald

摘　　要：目的探讨大柴胡汤加减治疗对原发性肝癌(HCC)肝动脉内化疗栓塞术(TACE)术后栓塞综合征症状持续时间、肝功能和生活质量的改善。方法选取我院100例HCC TACE术后栓塞综合征患者,将其分为治疗组(50例)和对照组(50例)。治疗组术后第1天给予大柴胡汤加减治疗,疗程为1周,其余处理同对照组;对照组给予常规对症治疗。结果治疗组的腹痛、发热、呕吐持续时间均短于对照组(P<0.05),治疗组的生活质量好转稳定率较对照组显著提高(P=0.042),治疗组术后第7天谷丙转氨酶(ALT)、谷草转氨酶(AST)和总胆红素(TBIL)较术后第2天显著改善(P<0.01),ALT、AST改善疗效优于对照组(P<0.05)。结论大柴胡汤加减可改善肝癌介入术后栓塞综合征。Objective To observe the efficacy of Dachaihu Decoction in the treatment of primary hepatocellular carcinoma （HCC） patients with embolism syndrome after interventional therapy. Methods 100 patients with HCC in our hospital were divided into treatment group （50 cases） and control group （50 cases）. Both of the two groups were treated with general treatment. Daehaihu Decoction was administered in the treatment group for seven days after surgery. Results The duration of vomiting, fever and abdomen pain in the treatment group were shorter than those in the control group （P 〈 0.05）. The patients with better quality of life in the treatment group more improved significantly than that in the control group （P = 0.042）. The levels of AST and ALT were lower after treatment in the treatment group than thaose in the control group （P 〈 0.05）. Conclusion Dachaihu Decoction can improve embolism syndrome after interventional therapy on HCC.

关 键 词：原发性肝癌 栓塞后综合征 大柴胡汤 生活质量 

分 类 号：R735.7[医药卫生—肿瘤]